AstraZeneca to acquire Neogene for up to $320m
November 29, 2022Sales and Marketing
AstraZeneca has announced that it is planning to buy Neogene for up to $320m. Biotechnology group Neogene has a focus …
Full-Life Technologies to acquire Focus-X Therapeutics
November 29, 2022Sales and Marketing
Full-Life Technologies, a fully integrated global radiotherapeutics company, has announced that they have agreed to acquire US-based Focus-X Therapeutics.
Siemens Healthineers and Atrium Health team up in $140m deal
November 29, 2022Sales and Marketing
Atrium Health, a US-based non-profit health provider, has signed a partnership with Siemens Healthineers to buy $140m worth of healthcare …
Scott Curley
November 28, 2022Business Services
Following a positive NICE recommendation for VAZKEPA® (icosapent ethyl), which has allowed Amarin to continue with its commercial expansion, Amarin …
Bayer and Orion Corporation-developed prostate cancer treatment approved by NHS England and MHRA
November 28, 2022Medical Communications
NHS England and the Medicines and Healthcare products Regulatory Agency have approved a prostate cancer treatment, developed jointly by Bayar …
Brainomix and Pixyl partner to offer multiple sclerosis treatment
November 28, 2022Medical Communications
In a new partnership, UK-based medical software developer Brainomix will distribute Neuro.MS ‒ French medical imaging company Pixyl’s Software as …
C4X Discovery signs licensing deal worth up to $402m with AstraZeneca
November 28, 2022Sales and Marketing
Pioneering drug discovery company, C4X Discovery Holdings (C4XD) has signed a licensing agreement with AstraZeneca, worth up to $402m. The …
Two-dose chemotherapy drug enters clinical trial for cancer patients
November 28, 2022Research and Development
South Korean biotech firm Hyundai Bioscience’s innovative chemotherapy drug may be able to complete cancer treatments in two doses. The …
NHS nurses strike announced for 15 and 20 December
November 25, 2022Medical Communications
The Royal College of Nursing (RCN) has announced strikes on 15 and 20 December in a continuing pay dispute with …
NICE recommends new life-extending treatment for rare form of gastroesophageal cancer
November 25, 2022Medical Communications
Clinical evidence shows Bristol Myers Squibb’s nivolumab, with chemotherapy, could help extend the lives of patients with untreated HER2-negative, advanced …
The University of Bristol trial to test rapid checks for reduction of antibiotic prescriptions
November 24, 2022Business Services
The University of Bristol has begun a trial to see if the rapid testing of initial symptoms could cut the number …
Iveda reveals AI-driven caregiver assistant, IvedaCare
November 24, 2022Business Services
Iveda, a US-based technology company, has introduced their new cloud-based artificial intelligence (AI) assistant called IvedaCare. The company says they …
Dr Frank Mathias
November 23, 2022Dr Frank Mathias has been appointed as life science firm Oxford Biomedica’s new CEO. Dr Mathias will take on his …
Novo Nordisk suffers profit loss over obesity drug as manufacturing problems continue
November 23, 2022Sales and Marketing
Danish pharma company Novo Nordisk, has reported a 2% loss in their third quarter sales report, compared to the previous …
Lunit first SaMD in APAC region to secure CE mark and UKCA certification for AI-based radiology solution
November 23, 2022Research and Development
Lunit, a South Korean medical software company, has become the first software as a medical device (SaMD) company in the …
Haemophilia drug costing $3.5m per dose has been approved
November 23, 2022Sales and Marketing
CSL Behring’s haemophilia B gene therapy has recently been approved by US regulators, however the treatment has an enormous price …
SMC accepts HRT treatment Bijuve for use across NHS Scotland
September 13, 2022Manufacturing and Production
The SMC has accepted HRT treatment, Bijuve, for use across NHS Scotland. Bijuve is the first and only body-identical HRT …
New malaria vaccine demonstrates high efficacy
September 9, 2022Medical Communications
A new malaria vaccine could be pivotal in the fight against the deadly disease. This vaccine has been developed …
Self-sterilising plastic kills viruses such as COVID-19
September 9, 2022Medical Communications
Scientists from Queen’s University Belfast have developed a virus-killing plastic that could make it harder for bugs, such as COVID-19, …
Brainomix and Bridge Biotherapeutics enter artificial intelligence partnership
September 8, 2022Business Services
Brainomix – the AI-powered MedTech solutions company – and Bridge Biotherapeutics, a clinical-stage biotechnology company focused on developing novel drugs …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
